Analysts Set Roche Holding Ltd. (ROG) Target Price at $276.29

Shares of Roche Holding Ltd. (VTX:ROG) have received a consensus rating of “Buy” from the ten brokerages that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is CHF 273.

Several equities research analysts recently issued reports on the company. Jefferies Group LLC set a CHF 285 price target on Roche Holding and gave the stock a “buy” rating in a report on Friday, June 16th. BNP Paribas set a CHF 250 price target on Roche Holding and gave the stock a “neutral” rating in a report on Tuesday. Barclays PLC set a CHF 305 price objective on Roche Holding and gave the company a “buy” rating in a research note on Tuesday, June 13th. Goldman Sachs Group Inc set a CHF 335 price objective on Roche Holding and gave the company a “buy” rating in a research note on Thursday, June 15th. Finally, HSBC Holdings plc set a CHF 215 price objective on Roche Holding and gave the company a “sell” rating in a research note on Tuesday, June 6th.

Shares of Roche Holding (VTX:ROG) traded down 0.28% during trading on Friday, hitting CHK 252.40. 1,816,904 shares of the stock traded hands. Roche Holding has a 52 week low of CHK 218.30 and a 52 week high of CHK 273.00. The firm has a market cap of CHK 215.04 billion and a P/E ratio of 21.97. The company has a 50-day moving average of CHK 261.91 and a 200-day moving average of CHK 248.78.

TRADEMARK VIOLATION NOTICE: “Analysts Set Roche Holding Ltd. (ROG) Target Price at $276.29” was originally posted by Mideast Time and is the property of of Mideast Time. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.mideasttime.com/analysts-set-roche-holding-ltd-rog-target-price-at-276-29/1800697.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.